ReadyCell Communications Department: 21 February 2024
| Programme | H2020 FETOPEN 2018–2020 |
| Budget | 3.822.695 Euros |
| Duration | 2021–2025 (48 months) |
| Consortium | Universitat de Barcelona (UB) (project leader), Danmarks Tekniske Universitet (DTU), Albert-Ludwigs-Universitaet Freiburg (ALU-FR), Leitat, MedTech Barcelona |
| Resources | StretchBio official website Cordis website |
StretchBio’s “Continuous two-dimensional Stretch monitoring of fresh tissue biopsies” overarching objective is to design, develop, fabricate and validate an advanced two-dimensional force sensor, leveraging an array of nanopillars, with a primary focus on advancing personalized cancer medicine by continuously monitoring mechanical stresses in ex vivo fresh tissue biopsies for optimized drug screening.
In this innovative project, ReadyCell plays a dual role. On one front, it actively contributes to technical tasks by assessing the biocompatibility and adhesion properties of Caco-2 cells on nanodevices while simultaneously refining the interface that connects these nanodevices with biosamples.
Beyond its technical contributions, ReadyCell’s dominant position and extensive experience in the biomedical sector, coupled with its global network of distribution partners, enables the company not only to define but also implement highly effective strategies for the exploitation and technology transfer of StretchBio’s results.
